Enliven Therapeutics
ELVN
ELVN
35 hedge funds and large institutions have $33.6M invested in Enliven Therapeutics in 2021 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 12 increasing their positions, 9 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
46% less capital invested
Capital invested by funds: $61.8M → $33.6M (-$28.2M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $33K
Holders
35
Holding in Top 10
–
Calls
–
Puts
$33K
Top Buyers
| 1 | +$1.81M | |
| 2 | +$440K | |
| 3 | +$372K | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
+$351K |
| 5 |
Morgan Stanley
New York
|
+$90.3K |
Top Sellers
| 1 | -$3.4M | |
| 2 | -$969K | |
| 3 | -$676K | |
| 4 |
Walleye Capital
New York
|
-$204K |
| 5 |
Walleye Trading
New York
|
-$176K |